Prof Zaal Kokaia | Stem Cells | Best Researcher Award |

Posted on by ScienceFather

Prof. Zaal Kokaia | Stem Cells | Best Researcher Award.

Lund University,Sweden

Professional Profiles:

SCOPUS

ORCID

GOOGLE SCHOLAR 

👨‍🎓 Bio Summary:

Prof. Zaal Kokaia is a distinguished figure in experimental medical research, specializing in stem cells and restorative neurology. Currently serving as Professor of Experimental Medical Research at Lund University’s Faculty of Medicine since January 2008, he also heads the Laboratory of Stem Cells & Restorative Neurology at Lund Stem Cell Center, University Hospital BMC B10, Lund, Sweden.

🎓 Education:

He earned his Master of Sciences in Biology, specializing in Biology and Chemistry education, from Tbilisi State University in 1984. Following this, Prof. Kokaia completed his Candidate of Biological Sciences (PhD) at the I. Beritashvili Institute of Physiology, Tbilisi, Georgia, in 1987. He obtained his Doctor of Philosophy (PhD) from the Faculty of Medicine, University of Lund, Sweden, in 1995, and later achieved his Doctor of Sciences (DSc) from the I. Beritashvili Institute of Physiology in Tbilisi, Georgia, in 1997. In 1999, he was appointed Docent of Experimental Neurology at the Faculty of Medicine, Lund University.

🔍 Research Focus:

Prof. Kokaia’s research primarily focuses on stem cells and their applications in restorative neurology, aiming to develop innovative therapies for neurological disorders. His work has significantly contributed to understanding neuronal replacement and regeneration mechanisms in the adult brain, particularly after stroke.

🏆 Honors & Awards:

Throughout his career, Prof. Kokaia has been recognized with numerous prestigious awards, including the Research Award from the King Gustav V and Queen Victoria’s Foundation in 2004, the Petre Sarajishvili Medal for his contribution to neuro-education in Georgia in 2009, and the Bengt Falck Prize in Neuroscience by Lund University in 2020.

Professional Experience: 💼

His professional journey includes pivotal roles such as Coordinator of the EU consortium StemStroke (2006-2009) and Coordinator of the EU consortium TargetBraIn (2011-2016). He has also served as Director of the Lund Stem Cell Center (2011-2020) and held memberships in various scientific advisory boards and policy committees.

 📚 Top Noted Publications :

Neuronal replacement from endogenous precursors in the adult brain after stroke

Authors: A Arvidsson, T Collin, D Kirik, Z Kokaia, O Lindvall

Journal: Nature Medicine

Volume: 8

Issue: 9

Pages: 963-970

Citations: 3636

Year: 2002

Inflammation is detrimental for neurogenesis in adult brain

Authors: CT Ekdahl, JH Claasen, S Bonde, Z Kokaia, O Lindvall

Journal: Proceedings of the National Academy of Sciences

Volume: 100

Issue: 23

Pages: 13632-13637

Citations: 1879

Year: 2003

Stem cell therapy for human neurodegenerative disorders–how to make it work

Authors: O Lindvall, Z Kokaia, A Martinez-Serrano

Journal: Nature Medicine

Volume: 10

Supplement: 7

Pages: S42-S50

Citations: 1244

Year: 2004

Stem cells for the treatment of neurological disorders

Authors: O Lindvall, Z Kokaia

Journal: Nature

Volume: 441

Issue: 7097

Pages: 1094-1096

Citations: 1055

Year: 2006

Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures

Authors: J Bengzon, Z Kokaia, E Elmér, A Nanobashvili, M Kokaia, O Lindvall

Journal: Proceedings of the National Academy of Sciences

Volume: 94

Issue: 19

Pages: 10432-10437

Citations: 975

Year: 1997

Author Metrics 📊 : 

He holds an impressive H-index of 74 (Web of Science) and 81 (Google Scholar), with total citations exceeding 32,000. His publications have been cited over 24,000 times, highlighting the influence and relevance of his work in academia.

📅 Research Timeline:

His research timeline spans from foundational academic training in Georgia and Sweden in the late 1980s to his current leadership and pioneering research at Lund University. Prof. Kokaia’s contributions have consistently pushed the boundaries of stem cell research and restorative neurology, impacting both scientific understanding and clinical applications.

Dr Roberto Lugo | Clinical Research Award | Best Researcher Award |

Posted on by ScienceFather

Dr. Roberto Lugo | Clinical Research Award | Best Researcher Award.

Hospital Regional de Alta Especialidad de la Península de Yucatán-IMSS Bienestar ,Mexico

Professional Profiles:

SCOPUS

GOOGLE SCHOLAR

👨‍🎓 Bio Summary:

Dr. Roberto Lugo is a Health Researcher based in Merida, Mexico. 🇲🇽 He is a researcher at the Hospital Regional de Alta Especialidad de la Peninsula de Yucatan and a member of the National System of Investigators. With over twenty years of experience, Dr. Lugo specializes in cancer research and chronic kidney disease. He has a strong background in designing and leading scientific projects, collaborating with national and international research networks, and managing molecular and cellular biology laboratories. His expertise also includes image analysis, statistical analysis of biological data, signal processing, mathematical modeling, and molecular techniques. Dr. Lugo holds a PhD in Biomedicine from the Universitat de Barcelona, a Master’s in Biomedical Engineering from the Institute for Bioengineering of Catalonia, Universitat de Barcelona, and a Bachelor’s in Biochemistry Engineering from the Instituto Tecnologico de Merida.

🎓 Education:

Dr. Lugo earned his PhD in Biomedicine from the Universitat de Barcelona, focusing on the study of the phenotypic heterogeneity of Tumor-Associated Fibroblasts in Lung Cancer. He completed his Master’s in Biomedical Engineering at the Institute for Bioengineering of Catalonia, where he worked on Ion-Selective Electrode development for pH detection. He obtained his Bachelor’s in Biochemistry Engineering from the Instituto Tecnologico de Merida, conducting research on the effects of temperature on the quality characteristics of dehydrated habanero chili peppers.

🔍 Research Focus:

Dr. Lugo’s research focuses on cancer, particularly the phenotypic heterogeneity of Tumor-Associated Fibroblasts in Lung Cancer. He also studies chronic kidney disease and its association with urinary stone composition, surgical resection impact on survival in gastric cancer patients, and the relationship between metabolic syndrome and hyperuricemia.

🏆 Honors & Awards:

Dr. Lugo has received several honors and awards for his contributions to the field of biomedical research.

Professional Experience: 💼

Dr. Lugo has over twenty years of experience in biomedical research, with a focus on cancer and chronic kidney disease. He has led and supervised scientific projects, collaborated with research networks, managed laboratories, and presented findings at national and international conferences.

📚 Top Noted Publications :

Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts – This study, published in Carcinogenesis in 2015, explores the role of DNA methylation in non-small cell lung cancer-associated fibroblasts, highlighting its potential impact on cancer development and progression.

Matrix Stiffening and β1 Integrin Drive Subtype-Specific Fibroblast Accumulation in Lung Cancer – Published in Molecular Cancer Research in 2015, this research investigates how matrix stiffening and β1 integrin contribute to subtype-specific fibroblast accumulation in lung cancer, shedding light on mechanisms driving cancer progression.

Epithelial contribution to the profibrotic stiff microenvironment and myofibroblast population in lung fibrosis – This study, published in Molecular Biology of the Cell in 2017, examines the contribution of epithelial cells to the profibrotic stiff microenvironment and myofibroblast population in lung fibrosis, providing insights into the disease mechanism.

Miniaturizable ion-selective arrays based on highly stable polymer membranes for biomedical applications – Published in Sensors in 2014, this research focuses on the development of miniaturizable ion-selective arrays based on highly stable polymer membranes for biomedical applications, demonstrating potential advancements in biomedical sensor technology.

Dietary strategies by foods with antioxidant effect on nutritional management of dyslipidemias: a systematic review – This systematic review, published in Antioxidants in 2021, explores dietary strategies involving foods with antioxidant effects for the nutritional management of dyslipidemias, offering insights into potential dietary interventions for managing lipid disorders.

Author Metrics 📊 : 

Dr. Lugo’s publications have received attention and citations, indicating their impact and contribution to the field of biomedical research.

📅 Research Timeline:

Throughout his career, Dr. Lugo has held positions at various institutions, including the International Iberian Nanotechnology Laboratory, Hospital Juarez de Mexico, the University of Oxford, and the Universidad Autonoma de Yucatan. He has contributed to projects focusing on cancer research, chronic kidney disease, and other areas of biomedical research.

Prof Dr Federico Lavorini | Medicine and Dentistry | Best Research Article Award

Posted on by ScienceFather

Prof Dr. Federico Lavorini, Medicine and Dentistry, Best Research Article Award.

Università di Firenze, Italy

Professional Profiles:

SCOPUS

ORCID

GOOGLE SCHOLAR 

💡Bio Summary : 

Dr. Federico Lavorini, born on June 16, 1965, in Pistoia, Italy 🇮🇹, is a distinguished Professor and Chair of Respiratory Medicine at the University of Florence. He serves as the Head of the Respiratory and Critical Care Unit at Careggi University Hospital in Florence. With a career spanning over three decades, Dr. Lavorini has made significant contributions to the fields of respiratory medicine, diagnostics, and therapeutics of inhaled drugs.

👩‍🔬 Education:

Dr. Federico Lavorini embarked on his academic journey in Pistoia, Italy, attending Classic High School “N. Forteguerri” from 1979 to 1984 🏫. He continued his pursuit of knowledge at the University of Florence, graduating with honors from the School of Medicine and Surgery in 1991 🎓. Driven by a passion for respiratory health, he further specialized in Pulmonary Disease, completing the Postgraduate School at the University of Florence from 1992 to 1996 🫁. His academic prowess culminated in a Ph.D. in Applied Pathophysiology, awarded by the University of Florence in the years 1996-2000 🧪. These formative years laid the foundation for Dr. Lavorini’s distinguished career in respiratory medicine and research.

🔍 Research Focus:

Dr. Lavorini’s research is centered around:

Diagnostics and therapeutics of inhaled drugs, emphasizing novel drug delivery methods for managing asthma and COPD. Intractable cough diagnosis and treatment, evaluating cough motor components and sensitivity in patients with respiratory and non-respiratory diseases. Asthma, focusing on controlling breathing and assessing lung function in patients, along with methods to aid correct inhaler usage.

👩‍💼 Professional Journey:

Consultant in Respiratory Medicine, Careggi University Hospital, Florence (2000-2018). Professor of Respiratory Medicine, University of Florence (2018-). Head of Respiratory Unit, Careggi University Hospital, Florence (2018-).

🏆 Honors & Awards:

Board certified in Pulmonary Disease (1996).

Ph.D. in Applied Pathophysiology (2000).

Co-Chair of the European Respiratory Society/International Society in Aerosol Medicine Guidelines on inhalation devices for asthma and COPD treatment (2018).

📚 Top Noted Publications :

Effect of Incorrect Use of Dry Powder Inhalers on Management of Patients with Asthma and COPD

Authors: F Lavorini, A Magnan, JC Dubus, T Voshaar, L Corbetta, M Broeders, …

Journal: Respiratory Medicine

Year of Publish: 2008

Citation: 102(4), 593-604

Index: 814

Impaired Immune Cell Cytotoxicity in Severe COVID-19 is IL-6 Dependent

Authors: A Mazzoni, L Salvati, L Maggi, M Capone, A Vanni, M Spinicci, …

Journal: The Journal of Clinical Investigation

Year of Publish: 2020

Citation: 130(9), 4694-4703

Index: 490

Critical Inhaler Errors in Asthma and COPD: A Systematic Review of Impact on Health Outcomes

Authors: OS Usmani, F Lavorini, J Marshall, WCN Dunlop, L Heron, E Farrington, …

Journal: Respiratory Research

Year of Publish: 2018

Citation: 19, 1-20

Index: 360

Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes

Authors: DB Price, M Román-Rodríguez, RB McQueen, S Bosnic-Anticevich, …

Journal: The Journal of Allergy and Clinical Immunology: In Practice

Year of Publish: 2017

Citation: 5(4), 1071-1081. e9

Index: 359

The First Tissue-Engineered Airway Transplantation: 5-Year Follow-up Results

Authors: A Gonfiotti, MO Jaus, D Barale, S Baiguera, C Comin, F Lavorini, …

Journal: The Lancet

Year of Publish: 2014

Citation: 383(9913), 238-244

Index: 345

Retail Sales of Inhalation Devices in European Countries: So Much for a Global Policy

Authors: F Lavorini, CJ Corrigan, PJ Barnes, PRN Dekhuijzen, ML Levy, …

Journal: Respiratory Medicine

Year of Publish: 2017

Citation: 105(7), 1099-1103

📊 Author Metrics:

Member of editorial boards for journals like Canadian Respiratory Journal, Journal of Aerosol Medicine, and more.

Member of international research groups, including the Respiratory Effectiveness Group (REG) and the European Respiratory Society.

📅 Research Timeline:

1980s-1990s: Student internships and early clinical exposure at the University of Florence.

2000s: Transitioned into a consultant role, initiated research in diagnostics and therapeutics of inhaled drugs.

2010s: Advanced to Head of Respiratory Unit, expanded research into cough and asthma control.

2018+: Established as a Professor of Respiratory Medicine, leading international guidelines on inhalation devices.

 

Prof. Dr. Federico Lavorini has left an indelible mark on the field of respiratory medicine, spearheading impactful research that has significantly advanced our understanding of inhaler use, immune responses in severe COVID-19, and pioneering tissue-engineered airway transplantation. His extensive body of work, ranging from the critical examination of inhaler errors to unraveling the IL-6 dependence in COVID-19, reflects his commitment to enhancing patient outcomes. With a career spanning over three decades, Prof. Lavorini’s contributions have not only shaped clinical practices but have also paved the way for innovative approaches in regenerative medicine. His dedication to unraveling complexities in respiratory care underscores the critical importance of correct inhaler techniques and informs global perspectives on inhalation device policies. 🌐🫁🔬 In the vast landscape of respiratory research, Prof. Dr. Federico Lavorini stands as a trailblazer, leaving a lasting impact that resonates across diverse aspects of patient care and scientific inquiry. 🌟